Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy

Zhengze Lu , Yang Long , Xingli Cun , Xuhui Wang , Jianping Li , Ling Mei , Yiliang Yang , Man Li , Zhirong Zhang and Qin He *
Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China. E-mail: qinhe@scu.edu.cn; Fax: +86-28-85502532; Tel: +86-28-85502532

Received 2nd May 2025 , Accepted 2nd May 2025

First published on 13th May 2025


Abstract

Correction for ‘A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy’ by Zhengze Lu et al., Nanoscale, 2018, 10, 9957–9970, https://doi.org/10.1039/C8NR01184B.


The authors regret that an incorrect version of Fig. S18 was included in the originally published article. The correct version of Fig. S18 is shown below, the ESI file has also been updated.


image file: d5nr90093j-u1.tif
Fig. S18 H&E staining analysis for major organs of CT26 tumor-bearing mice on the 20th day of treatment. (Black scale bar = 100 μm, red scale bar = 250 μm.) Arrows indicated the damaged cardiomyocytes.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.